08.09.24 -- The Power Of Data Sharing: Revolutionizing Site Performance In Clinical Studies

In an era of tightening capital and heightened regulatory scrutiny, standardizing data collection in clinical trials emerges as a pivotal strategy for efficiency and scalability.

IQVIA Technologies' Vice President and General Manager of IRT Kevin Landells and Senior Director of Product Management of IRT Stefan Dürr delve into real-world examples and practical AI applications.

This post explores key measurement tools in Atopic Dermatitis (AD) clinical trials, specifically EASI and Total BSA, highlighting the importance of accurate measurement and strategies to improve data quality.

Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.

Discover how advancements in personalized medicine and innovative trial approaches are reshaping the future of healthcare, offering unparalleled insights into individual health journeys.

Read this high-level summary to better understand how artificial intelligence can improve product quality, accelerate decision-making, reduce operational costs, and enable preventive maintenance services.

Risk-based monitoring increases overall trial oversight by balancing “must-do” data collection and “nice-to-have” data against site and patient burden — and, more importantly, patient safety.